Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.

The field of liquid biopsy has seen extensive growth in recent decades, making it one of the most promising areas in molecular diagnostics. Circulating cell-free DNA (ccfDNA) especially is used as an analyte in a growing number of diagnostic assays. These assays require specified preanalytical workf...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thorsten Voss, Andrea Ullius, Maike Schönborn, Uwe Oelmüller
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/96d40d8b53b2441486b66819fc19b795
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:96d40d8b53b2441486b66819fc19b795
record_format	dspace
spelling	oai:doaj.org-article:96d40d8b53b2441486b66819fc19b7952021-12-02T20:05:12ZSensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.1932-620310.1371/journal.pone.0253401https://doaj.org/article/96d40d8b53b2441486b66819fc19b7952021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253401https://doaj.org/toc/1932-6203The field of liquid biopsy has seen extensive growth in recent decades, making it one of the most promising areas in molecular diagnostics. Circulating cell-free DNA (ccfDNA) especially is used as an analyte in a growing number of diagnostic assays. These assays require specified preanalytical workflows delivering ccfDNA in qualities and quantities that facilitate correct and reliable results. As each step and component used in the preanalytical process has the potential to influence the assay sensitivity and other performance characteristics, it is key to find an unbiased experimental setup to test these factors in diagnostic or research laboratories. We defined one such setup by using blood from healthy subjects and commercially available products for blood collection, spike-in material, ccfDNA isolation, and qPCR assays. As the primary read-out, we calculated the probit model-based LOD95 (limit of detection of the 95th percentile) from the qPCR assay results. In a proof of principle study we tested two different but widely used blood ccfDNA profile stabilization technologies in blood collection tubes, the Cell-Free DNA BCT and the PAXgene Blood ccfDNA Tube. We tested assays for three different EGFR gene mutations and one BRAF gene mutation. The study design revealed differences in performance between the two tested technologies for all four mutations. In conclusion, we successfully established a blueprint for a test procedure capable of verifying and validating a liquid biopsy workflow from blood collection to the analytical result.Thorsten VossAndrea UlliusMaike SchönbornUwe OelmüllerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0253401 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Thorsten Voss Andrea Ullius Maike Schönborn Uwe Oelmüller Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.
description	The field of liquid biopsy has seen extensive growth in recent decades, making it one of the most promising areas in molecular diagnostics. Circulating cell-free DNA (ccfDNA) especially is used as an analyte in a growing number of diagnostic assays. These assays require specified preanalytical workflows delivering ccfDNA in qualities and quantities that facilitate correct and reliable results. As each step and component used in the preanalytical process has the potential to influence the assay sensitivity and other performance characteristics, it is key to find an unbiased experimental setup to test these factors in diagnostic or research laboratories. We defined one such setup by using blood from healthy subjects and commercially available products for blood collection, spike-in material, ccfDNA isolation, and qPCR assays. As the primary read-out, we calculated the probit model-based LOD95 (limit of detection of the 95th percentile) from the qPCR assay results. In a proof of principle study we tested two different but widely used blood ccfDNA profile stabilization technologies in blood collection tubes, the Cell-Free DNA BCT and the PAXgene Blood ccfDNA Tube. We tested assays for three different EGFR gene mutations and one BRAF gene mutation. The study design revealed differences in performance between the two tested technologies for all four mutations. In conclusion, we successfully established a blueprint for a test procedure capable of verifying and validating a liquid biopsy workflow from blood collection to the analytical result.
format	article
author	Thorsten Voss Andrea Ullius Maike Schönborn Uwe Oelmüller
author_facet	Thorsten Voss Andrea Ullius Maike Schönborn Uwe Oelmüller
author_sort	Thorsten Voss
title	Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.
title_short	Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.
title_full	Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.
title_fullStr	Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.
title_full_unstemmed	Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.
title_sort	sensitivity assessment of workflows detecting rare circulating cell-free dna targets: a study design proposal.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/96d40d8b53b2441486b66819fc19b795
work_keys_str_mv	AT thorstenvoss sensitivityassessmentofworkflowsdetectingrarecirculatingcellfreednatargetsastudydesignproposal AT andreaullius sensitivityassessmentofworkflowsdetectingrarecirculatingcellfreednatargetsastudydesignproposal AT maikeschonborn sensitivityassessmentofworkflowsdetectingrarecirculatingcellfreednatargetsastudydesignproposal AT uweoelmuller sensitivityassessmentofworkflowsdetectingrarecirculatingcellfreednatargetsastudydesignproposal
_version_	1718375496776941568

Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal.

Ejemplares similares